945543-24-8

Basic information

• Product Name: 2,4-Dichloropyridine-3-methanol
• Synonyms: 2,4-Dichloropyridine-3-methanol;(2,4-Dichloro-3-pyridyl)methanol
• CAS NO: 945543-24-8
• Molecular Formula: C6H5Cl2NO
• Molecular Weight: 178.016
• Mol File: 945543-24-8.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,4-Dichloropyridine-3-methanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4-Dichloropyridine-3-methanol(945543-24-8)
• EPA Substance Registry System: 2,4-Dichloropyridine-3-methanol(945543-24-8)

Safety Data

• Hazardous Substances Data: 945543-24-8(Hazardous Substances Data)

Usage

General Description

2,4-Dichloropyridine-3-methanol is a chemical compound with the molecular formula C6H5Cl2NO. It is a derivative of pyridine and contains two chlorine atoms and a hydroxyl group. 2,4-Dichloropyridine-3-methanol is used in various industrial applications, including the production of agrochemicals and pharmaceuticals. It is also used as an intermediate in the synthesis of other organic compounds. Due to its chemical structure and properties, 2,4-Dichloropyridine-3-methanol is considered to be toxic and may pose health and environmental risks if not handled properly.

Upstream product

• 134031-24-6 2,4-dichloro-3-pyridine Carboxaldehyde 
• 26452-80-2 2,4-dichloropyridine 
• 541-41-3 chloroformic acid ethyl ester 
• 262423-77-8 2,4-dichloronicotinic acid 
• 607351-40-6 2,4-dichloropyridine-3-carbonyl chloride 

Downstream Products

• 945543-26-0 3-(bromomethyl)-2,4-dichloropyridine 

Relevant articles and documents

RORγ MODULATORS

The invention provides an RORγ receptor agonist comprising a compound of formula (I), wherein the variables are as defined herein. These compounds are analogous to known RORγ receptor antagonists. The invention further provides a method of activating -the nuclear receptor RORγ, comprising -contacting the RORγ with an effective amount or concentration of a compound of the invention; and a method of treating cancer in a patient, comprising administering to the patient an effective dose of a compound of the invention.

SPIRO-CYCLIC AMINE DERIVATIVES AS S1P MODULATORS

The present invention relates spiro- cyclic amine derivatives of the formula (I) wherein R1; R2; R3; Q; -W-T-; R5; Z; and A have the definitions provided in the claims; or a pharmaceutically acceptable salt, a solvate or hydrate thereof or one or more N-oxides thereof. The compounds of the invention have affinity to S1P receptors and may be used in the treatment, alleviation or prevention of diseases and conditions in which (a) SIP receptor (s) is (are) involved

8-OXY-QUINOLINE DERIVATIVES AS BRADYKININ B2 RECEPTOR MODULATORS

The present invention is related to compound of the formula (I): or a pharmacologically acceptable salt, solvate, or hydrate thereof, wherein A is a 6-membered heteroaryl having from 1 to 3 heteroatoms, each independently selected from N or O and the other substituents are defined as in the claims.